Spectral AI Raises $7.6 Million in Institutional Funding Round
Spectral AI, Inc. (Nasdaq: MDAI), an artificial intelligence company specializing in medical diagnostics for wound care, has announced the pricing of a $7.6 million offering to support the continued development and expansion of its DeepView® System. The financing includes the issuance of 4,000,000 shares of common stock and pre-funded warrants at $1.90 per share, along with accompanying warrants exercisable at $2.51 per share. The funds will be used to advance the company's AI-powered technology, expand clinical indications, and prepare for commercial readiness in 2026. Northland Capital Markets served as the exclusive placement agent, and Reed Smith, LLP acted as counsel for the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spectral Ai Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9550953-en) on October 23, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。